Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share
-
Shares outstanding
-
49,938,272
-
Total 13F shares
-
11,420,830
-
Share change
-
+4,092,395
-
Total reported value
-
$341,203,000
-
Price per share
-
$29.87
-
Number of holders
-
39
-
Value change
-
+$123,064,104
-
Number of buys
-
26
-
Number of sells
-
11
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC) as of Q1 2021
As of 31 Mar 2021,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,420,830 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., Logos Global Management LP, Atlas Venture Advisors, Inc., FIL Ltd, SAMLYN CAPITAL, LLC, EVENTIDE ASSET MANAGEMENT, LLC, and Verition Fund Management LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.